22 May 2013
Keywords: reaferon, launch, japan, south, korea-based, dong, shin
Article | 03 April 1995
- South Korea-based Dong Shin Pharmaceutical has launched Reaferon (alpha interferon) in Japan for the treatment of acute hepatitis B. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.